Tsukimi Yasuhiro | Inflammation Drug Discovery Unit Pharmaceutical Research Division Takeda Pharmaceutical Company Limi
スポンサーリンク
概要
- 同名の論文著者
- Inflammation Drug Discovery Unit Pharmaceutical Research Division Takeda Pharmaceutical Company Limiの論文著者
関連著者
-
Tsukimi Yasuhiro
Inflammation Drug Discovery Unit Pharmaceutical Research Division Takeda Pharmaceutical Company Limi
-
TSUKIMI Yasuhiro
TRA Urology, Laboratory-4, Research Center Kyoto, Bayer Yakuhin Ltd.
-
Tsukimi Y
Tra Urology Laboratory-4 Research Center Kyoto Bayer Yakuhin Ltd.
-
TSUKIMI Yasuhiro
Department of New Drug Research Laboratories, Technical Headquarters, Shinnippon Pharmaceutical, Inc
-
Tsukimi Yasuhiro
Department Of Applied Pharmacology Kyoto Pharmaceutical University
-
Imanishi Akio
Exploratory Research Center Pharmaceutical Research Division Takeda Pharmaceutical Company Limited
-
USHIRO Toshihisa
Department of New Drug Research Laboratories, Technical Headquarters, Shinnippon Pharmaceutical, Inc
-
Tanaka H
Department Of New Drug Research Laboratories Technical Headquarters Shinnippon Pharmaceutical Inc
-
Matsumoto Hiroko
Tra Urology Laboratory-4 Research Center Kyoto Bayer Yakuhin Ltd.
-
TAJIMI Masaomi
TRA Urology, Laboratory-4, Research Center Kyoto, Bayer Yakuhin Ltd.
著作論文
- Studies on the Mechanism of Action of the Gastric H^+,K^+-ATPase Inhibitor SPI-447
- Bidirectional Regulation of Human Colonic Smooth Muscle Contractility by Tachykinin NK2 Receptors
- Inhibition of Gastric H^+,K^+-ATPase by 3-Amino-5-methyl-2-(2-methyl-3-thienyl)imidazo[1,2-a]thieno[3,2-c]pyridine, SPI-447
- Effects of NSAIDs on Bladder Function in Normal and Cystitis Rats : a Comparison Study of Aspirin, Indomethacin, and Ketoprofen
- Mechanism of Action by Which Aspirin Alleviates Detrusor Hyperactivity in Rats
- Recent Advances in Gastrointestinal Pathophysiology : Role of Heat Shock Proteins in Mucosal Defense and Ulcer Healing
- Bidirectional Regulation of Human Colonic Smooth Muscle Contractility by Tachykinin NK_2 Receptors
- Establishment and Validation of a Rabbit Model for In Vivo Pharmacodynamic Screening of Tachykinin NK_2 Antagonists